Financial Data Sheet R D Fund Large Projects

Financial Data Sheet
Instructions
1 The Financial Data Sheet (FDS) is used by Enterprise Ireland to generate a standard financial model and
to calculate standard financial ratios. It is also employed to compute an economic cost benefit ratio.
2 The spreadsheet is password protected
3 Please do not insert additional rows or columns nor delete existing ones. Doing so may distort the results of
the financial model and financial ratios.
4 All monetary figures should be entered in thousands of Euro (000's).
5 Please fill in all applicable cells on Company Input Sheet 1 & 2, leaving non-relevant cells empty.
Company Input Sheet 1 contains historic and projected financial information, including P&L and Balance Sheets.
Company Input Sheet 2 contains a pro-forma monthly cash flow for the next 12 months
A monthly
required;
however,where
it is not
necessary
it in
format, asgrants
alternative formats will be accepted.
Company
Inputcashflow
Sheet 3ismust
be completed
the
companyto
is submit
applying
forthis
employment
6 The Base year is normally selected as the latest accounting period which has elapsed, regardless of
whether audited accounts are available.
New Start-Ups should use 'Current Year' (Base Year+1) for first year of trading.
e.g. When completing the FDS in 2014 with a December year-end should select 31/12/2013 as base year.
However, if at least 10 months of management accounts are available and there is a reasonable expectation
that the end of year projections will be met, the current financial year is the base year.
e.g. When completing the FDS in October 2014 with a December year-end, 31/12/2014 should be selected as the base year.
7 Please ensure that the totals of the Balance Sheet are balanced i.e. that the Net Assets in each year equal the total of the 'Financed By' section.
8 Additional clarification for each field is available by placing the mouse cursor over all cells with a red triangle located in the upper right corner
9 The FDS financial model is based on the assumption that short term funding is fully utilised i.e. invoicing discounting and overdraft facilities are drawn down in full.
Colour Key
White cells represent areas available for Company input.

Yellow shading represents automatically calculated formulae [password protected].
Blue shading represents cells requiring input from Enterprise Ireland staff.
Last Update
Version 11.0
16-May-14

Company Name
Single Entity
Please note Current Year date is greater than 10 months, it is reasonable to expect the company to meet its end
Information required prior to completing Profit & Loss and Balance Sheet sections
Base Year-2
Year End
No. of Global Employees @ y/e (incl Irish employment)
No. of Irish Based Employees @ y/e
No. of Global R&D Employees @y/e
No. of Irish Based R&D Employees @ y/e
Total Irish Labour Costs (000's)
Capitalised R&D (000's)
VAT / PAYE / PRSI paid / (Received) in year
Bank Overdraft (Facility Limit for Projected Years)
Invoice discounting (Projected Year End Balance)
Site/Buildings Purchase
Site/Buildings Modifications
New Machinery / other Capex
Intangible asset (Excl Capitalised R&D)
Promoters' Equity Investment / (Divestment)
Other Equity Investment / (Divestment)
Dividends Paid to EI
Other Dividends Paid
31/12/11
Base Year-1
31/12/12
Base Year
31/12/13
Current Year
31/12/14
Profit & Loss

Year End
Account Status
Sales
Own Product / Service Produced in Ireland & Exported
Own Product / Service Produced Abroad & sold Abroad
Own Product / Service Produced & Sold in Ireland
Distribution Sales of Other Co's Product
Total Sales
31/12/11
Audited
31/12/12
Audited
31/12/13
Management
31/12/14
Projected
000's
000's
000's
000's
Direct Labour
Purchases
Other Cost of Goods Sold
Cost of Sales
Gross Profit/(Loss)
Other Operating Expenses/(Gains)

Operating Expenditure
Operating Profit/(Loss) - EBITDA
Selling, General & Admin Expenses

Indirect Labour (excluding R&D Salaries)
R&D Salaries
Other R&D expenditure
R&D Expenditure
Interest Payable
Interest / Dividends (Receivable)
Depreciation
Amortisation
Grant Amortisation (This application only)
Remitted Profits to Ireland From Foreign Subsidiary
Non-Operating Expenses/(Gains)
Profit/(Loss) before Tax
Tax
Company Input Sheet 1
279797952.xlsx
Net Profit/(Loss)
Dividends
Profit Retained for the Year
Balance Sheet
Year End
31/12/11
31/12/12
000's
Fixed Assets
Intangible
Tangible Fixed Assets
Investments
Total Fixed Assets
Current Assets
Inventory
Trade Debtors
Bank/Cash
Connected Parties / Inter Company Loans
Prepayments / Other Debtors
Total Current Assets
31/12/13
000's
31/12/14
000's
000's
0
0
0
Current Liabilities
Bank Overdraft (Facility Limit in Projected Years)
Invoice discounting (YE Balance)
Short Term loans / Leasing (<1 year)
Trade Creditors
Accruals / Other Creditors
Total Current Liabilities
Net Current Assets
0
0
Liabilities > 1 Year

Long Term Loans
Leases
Directors / Shareholders Loans
EI Grant Liability (This application only)
Other Long Term Liabilities
Total Liabilities > 1 Year
Net Assets
Financed by
Preference Shares
EI Equity Assistance (This application only)
Ordinary Shares & Share Premium
Provisions/Grants/Other Reserves
Retained Earnings
Shareholders Funds
0
0
0
0
0
0
0
0
279797952.xlsx
Projected Cash Funding Table

Year End
31/12/10
31/12/11
000's
000's
31/12/12
31/12/14
000's
000's
Cash Flow Statement For the year ended

Add back; Depreciation / Amortisation
Working Capital (Increase)/Decrease

Stocks
Trade Debtors
Trade Creditors
Total
Operating Cash Inflow / (Outflow)
Capex - Tangible
Capex - Intangible
Capital Expenditure
Funding Inc/ (Dec)

OverDraft & Invoice Discounting Facility
0
0
Long Term Loans / Leasing / convertible

Convertible/Other Loans
0
0
Directors Loans
EI Equity
EI Grant
279797952.xlsx
of year projections - current year should be used as the base year in this case. Please Refer to instruction 6
Base Year+2
31/12/15
Base Year+3
31/12/16
Insert Additional Information

31/12/15
Projected
31/12/16
Projected
000's
000's
Please provide a description of Other
279797952.xlsx
Insert Additional Information

31/12/15
31/12/16
000's
000's
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
279797952.xlsx
31/12/15
31/12/16
000's
000's
0
0
0
0
0
0
0
0
279797952.xlsx
Summary Monthly Cashflow Statement for the NEXT 12 MONTHS

Month End
MM/YY
MM/YY
000's
MM/YY
000's
Total
MM/YY
000's
MM/YY
000's
MM/YY
000's
MM/YY
000's
MM/YY
000's
MM/YY
000's
MM/YY
000's
MM/YY
000's
MM/YY
000's
Dec-14
000's
000's
Operating Cash Inflow

Sales receipts - Non Invoice
Discounting Supported
Sales Receipts - Invoice

discounting
0
0
0
Other Revenue - specify

Other Revenue - specify
Non - Operating Cash Inflow
0
0
Loan 1
Loan 2
Non EI Equity/Grants
0
0
Promoters' Equity Investment

Other Equity Investment
EI Monies (This investment)

Total Cash Receipts
Operating Cash Payments
0
0
0
0
0
Payments to Creditors/Suppliers
Wages/Salaries
Other Cash Operating Expenses
Other Expense 1 - Specify
Other Expense 2 - Specify
Capital Investment
Dividends
0
0
Dividends Paid to EI
Other Dividends Paid
Non-Operating Cash Payments
Loan Repayment 2
0
0
Directors Loans/ Related Parties

Payments
Invoice Discounting Payments
Equity/Grants
0
0
EI Share/Grant Redemptions
Other Share Redemptions
Total Cash Inflow/(Outflow)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Opening Cash (Excl Short Term

Facilities)
Net Closing Cash (Excl Short Term

Facilities)
Inv Disc (Proj Month End Bal)
Net Closing Cash (Incl Short Term

Facilities)
Total Cash Payments
OverDraft Facility
279797952.xlsx
Sustainable Growth Analysis

Base Year-2
31/12/11
Audited
1
2
3
4
5
6
7
8
9
10
11
12
13
Additional Fixed Assets

Additional Working Capital Assets (Spontaineously Generated)
Capital Repayments (Loan & Lease)
Overdraft & ID Withdrawn
Directors or Connect Party Loans Withdrawn
Trade Working Capital withdrawn
Additional Financial Needs (AFN)
Financed By: Additional Trade Working Capital Advanced
Additional Termed Capital Advanced (Loan & Lease)
Retained Earnings
Cash Resources Utilised
Overdraft & ID Advanced
Directors or Connect Party Loans Advanced
Additional Financial Needs (AFN) - Unfunded
14
15
16
17
18
19
20
Additional Sales volume that can be funded from internal resources

Planned additional sales volume
Capital Intensity Ratio
Debt Equity Ratio
MSGR Drivers
Net Profit Margin
Asset Turnover Ratio
Equity Multiplier
0.00%
0.00%
28
Return on Total Assets

Return on Equity
Dividend Ratio
Maximum internal Growth Rate
0.00%
0.00%
0.00%
0.0%
29
Maximum Sustainable Growth Rate= MSGR
21
22
23
24
25
26
27
0.00%
0.00
1.00
0.0%
30
31
32
33
34
35
36
37
38
Ref
1
Organic Enterprise Growth (Less external equity injections)

Organic Enterprise Growth Rate
Growth in excess of projected MSGR
Movement in MSGR Drivers
Net Profit Margin
Asset Turnover Ratio
Equity Multiplier
Dividend Policy
Core Issues
Capital Intensity Requirement
Is asset investment absolutely n

Is there spare capacity in existi
Movement in Net Profit
Is volume component of sales m

Is gross margin component of m
Is expense component of move
Is component outside EBIT of
22 & 37
15 & 16 & 21 & 36
21 & 36
21 & 36
21 & 36
Key Questions
19 & 23 & 38
19 & 23 & 38
19 & 23 & 38
External Funding Capacity
What sources of external fundin

What is the cash available for d
What are the debt service requ
Base Year-1
Base Year
Current Year
Base Year+2
Base Year+3
31/12/12
Audited
31/12/13
Management
31/12/14
Projected
31/12/15
Projected
31/12/16
Projected
0
0
0
0
0
0
0
0
0
0
0
0
0
0
nced (Loan & Lease)
ns Advanced
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
What If
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00
1.00
0.00%
0.00
1.00
0.00%
0.00
1.00
0.00%
0.00
1.00
0.00%
0.00
1.00
0.00%
-
0.00%
0.00%
0.00%
0.0%
0.00%
0.00%
0.00%
0.0%
0.00%
0.00%
0.00%
0.0%
0.00%
0.00%
0.00%
0.0%
0.00%
0.00%
0.00%
0.0%
0.00%
0.00%
0.00%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0
0.0%
0.0%
0.00
0.00
0.0%
0
0.0%
0.0%
0.00
0.00
0.0%
0
0.0%
0.0%
0.00
0.00
0.0%
ey Questions
asset investment absolutely necessary to drive increase in sales?
there spare capacity in existing asset base - historic intensity rate?
volume component of sales movement attainable and what are the drivers?
gross margin component of movement attainable and what are the drivers?
expense component of movement realistic and what are the drivers?
component outside EBIT of movement realistic and what are the drivers?
What sources of external funding are available and the realistic probability of attaining it?
What is the cash available for debt service and what are its major drivers?
What are the debt service requirements and ratios and can they be varied?
Revenue Summary
11
Labo u r A nalys is
Expe ndi ture Analys is
31/12/12
31/12/13
Domestic Sales
31/12/14
31/12/15
International Sales
Em ploye e Nu m b er s
31/12/16
Re ven u e - Eur o
Exports
Re ve nu e
T o ta l Ope x
KPI's
35,000
Non R& D O pe x
CO S
R& D Exp end i ture
Summary of key profit & loss indicators
4,000
20,000
Euro
'000
3,000
Investments
15,000
Tangible Asstes
10,000
2,000
Intangible Assest
5,000
1,000
Deprec iation &

Amortisation
Capex
Revenue
31/12/14
31/12/15
31/12/16
-(5,000)
31/12/11
31/12/12
Total Sales
EBITDA
In di re c t La b ou r Co sts
Dire ct L abo ur Co sts
5,000
25,000
31/12/13
Iri sh Emp l oyee s

R&D Co sts
Fixed Asset Analysis
6,000
30,000
31/12/12
Gl oba l Emp lo ye e s
To ta l La b our Co sts
31/12/13
Gross Margin
31/12/14
31/12/15
EBIDTA
31/12/16
0
31/12/11
31/12/12
31/12/13
31/12/14
31/12/15
31/12/16
Net Margin
5000
Cashflow Analysis
4000
3000
Euro
2000
1000
0
-1000
Working Capital Analysis
Working Capi tal Analysi s
Analysis of Debt
Euro
Year
Euro
Days
ST L oa ns/Leases
Interest Pa yabl e
LT Loans
LT Leases
I nte rc ompa ny l oans
T ra de Debto rs
I nventory
Curre nt Li abi l i t i es
N et Worki n g Capi tal
T rade Cre di tors
Curre nt A sset s
Please select from the drop down boxes below to perform a simple scenario analysis, that will enable the user
to understand the impact of variances in sales & costs forecasts.
Please note the following assumptions
1. Debtors will be directly impacted as a result of a movement in sales
2. Creditors will be directly impacted as a result of a movement in Purchases
3. Stock will be directly impacted as a result of a movement in Purchases
4. In Scenario Test A, purchases is the only element of Total Cost of Sales category that is variable
5. I n cases where the value of Purchases is very low (or zero) Scenario Test B should be used
Scenario Test A
31/12/14
31/12/15
31/12/16
Sales
100%
100%
100%
Purchases only
100%
100%
100%
100%
100%
100%
Current Year
Base Year+2
Base Year+3
31/12/14
31/12/15
31/12/16
42004
42369
42735
000's
000's
000's
Profit & Loss - Scenario Test

Year End
Account Status
Total Sales
Purchases
Total Cost of Sales
Gross Profit/(Loss)
Net Profit/(Loss)
Balance Sheet - Scenario Test

Year End
31/12/14
31/12/15
31/12/16
000's
000's
000's
Stock
Debtors
Bank/Cash
Total Fixed Assets

Trade Creditors
Net Current Assets
Net Assets
Retained Earnings
Shareholders Funds
31/12/14
31/12/15
31/12/16
Stocks
Debtors
Creditors
Total
Capital Expenditure
OD & ID Facility
Long Term Bank Loans/Leasing
Related Parties
Directors Loans
EI Equity
EI Grant
Other Equity
Other Reserves
Net Movement in Cash
Opening Cash Balance
Closing Cash Balance - Available Funds
Overdraft Facility
Invoice Discounting Balance
Closing Cash (Excl Facilities i.e. net cash)
Financed by
Projected Cash Funding Table - Scenario Test

Working Capital (inc)/dec
Funding (inc)/dec
Scenario Test B
31/12/14
31/12/15
31/12/16
Sales
100%
100%
100%
Cost of Sales
100%
100%
100%
100%
100%
100%
Current Year
Base Year+2
Base Year+3
31/12/14
31/12/15
31/12/16
000's
000's
000's
Profit & Loss - Scenario Test

Year End
Account Status
Total Sales
Purchases
Total Cost of Sales
Gross Profit/(Loss)
Net Profit/(Loss)
Balance Sheet - Scenario Test

Year End
31/12/14
31/12/15
31/12/16
000's
000's
000's
Stock
Debtors
Bank/Cash
Net Current Assets
Net Assets
Total Fixed Assets

Trade Creditors
Financed by
Retained Earnings
Shareholders Funds
31/12/14
31/12/15
31/12/16
Stocks
Debtors
Creditors
Total
Capital Expenditure
OD & ID Facility
Short Term loans / Eeasing (<1 year)
Eong Term Bank Eoans/Eeasing
Convertible/Other Eoans
Related Parties
Directors Eoans
EI Equity
EI Grant
Other Equity
Other Reserves
Net Movement in Cash
Opening Cash Balance
Closing Cash Balance - Available Funds
Overdraft Facility
Invoice Discounting Balance
Closing Cash (Excl Facilities i.e. net cash)
Projected Cash Funding Table - Scenario Test

Working Capital (inc)/dec
Funding (inc)/dec
Scenario Test A
Scenario Test B

Company Name
Company Information
Region
Type of Company
Ownership/Strategic Control
Please Select
Please Select
Please Select
Employment Numbers
Base Year
Year End
Base Irish Employment Level
31/12/13
0
EI Funding
Development Adviser to input proposed grant and equity package as applicable.
Year End
Grants
EI Capital Grants
EI Employment Grants
EI HRD/Mgt Development Grants
EI R&D Grants
EI Marketing & Strategy Grants
Total Grants
Equity
EI Ordinary Shares
EI HPSU CCRPs
EI Preference Shares
Total EI Equity
Base Year+1
Base Year+2
Base Year+3
31/12/14
31/12/15
31/12/16
000's
000's
000's
Equity amount to be used for Value for Money measures

Value for Money measures
Cost per Job Inputs
Value For Money (VFM) (from CSS)
CEB Funding (Grant - past 7 years)
CEB Funding (Equity - past 7 years)
New Proposed Cancellations (Grant)
New Proposed Cancellations (Equity)
New Support
Total Support
Business Expansion Scheme (BES)*
BES Redemption amount
BES Redemption date
*If applicable
000's
Should be a negative amount

Should be a negative amount
0
0
0
DD/MM/YY
Assumptions For BC calculation

Repayable element of Capital Grant
0%
Capital Amount Waived
Cost Benefit Ratio

If you need assistance with this ratio, please contact Commercial Evaluation.
EI Cost Benefit Ratio
Please complete the above 'Company Information' section to calculate
the Cost Benefit Ratio.
Drivers of Cost Benefit Ratio

000's
Increase in Sales
Increase in Exports
Increase in Irish Payroll
Increase in Post Tax Profits
0
0
0
0
Impacts
EI Targets*
Base Year
Base Year+3
dd/mm/yy
dd/mm/yy
Sales (000s)
Exports (000s)
Employees (Irish Based)
Productivity**
0
0
0
n/a
Increase
('000)
0
0
0
n/a
%
0
0
0
n/a
Value for Money Measures

Ratio of
Increased
Export Sales
Benefit to Cost
Ratio
To EI Support
Total Support per Total Support per

Existing
Projected
Employees (Base Employees (Base
Year)
Year+3)*
'000
Ratio of 3:1
EI DA Input Sheet
'000
EI Funding Guidelines - justification required if exceeded

Minimum of 1
Max 15k / 25k Max 15k / 25k
279797952.xlsx
To insert the below tables into the Commercial Assessment (CA) Document please follow the below steps:
Step 1: Copy the Track Record & Projections Table into the CA document by Hi-lighting cells A15 to H70
Step 2: Open the CA document and place the cursor where you want the selected table to appear
Step 3: Using the mouse go to the Edit menu on the tool bar and left click on "Paste Special"
Step 4: A "Paste Special" pop up box will appear - select Microsoft Office Excel Worksheet Object and left click on OK
Step 5: Copy the Projected Cash Funding Table into the CA document by Hi-lighting cells A118 to H162
Step 6: Repeat steps 2 to 4
Step 7: Copy the Profit & Loss Table into the CA document by Hi-lighting cells A164 to H204
Step 9: Copy the Balance Sheet into the CA document by Hi-lighting cells A206 to H251
Track Record & Projections: Company Name

Month
Year End
Account Status
FDS Template as at
41775
Base Year-2
Dec-11
Audited
Base Year-1
Dec-12
Audited
Base Year
Dec-13
Management
Base Year+1
Dec-14
Projected
Base Year+2
Dec-15
Projected
Base Year+3
Dec-16
Projected
SALES & EXPORTS

Sales (000's)
Domestic Sales ('000s)
Exports (000's)
0
0
0
0
0
0
0
0
0
0
0
0
International Sales (000's)

Exports as % of Sales
0
n/a
0
n/a
0
n/a
0
n/a
0
n/a
0
n/a
International Sales as % of Sales
n/a
n/a
n/a
n/a
n/a
n/a
PROFITABILITY
Gross Profit / (Loss)
EBITDA
Net Profit/(Loss) (000's)
Gross Proft as a % of Sales
0
0
0
0
0
0
0
0
0
0
0
0
0
n/a
0
n/a
0
n/a
0
n/a
0
n/a
0
n/a
Operating as a % of Sales
n/a
n/a
n/a
n/a
n/a
n/a
EBITDA as a % of Sales
n/a
n/a
n/a
n/a
n/a
n/a
Net Margin
n/a
n/a
n/a
n/a
n/a
n/a
Return on Shareholders' Funds
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
GROWTH
Sales growth %
Export growth %
PRODUCTIVITY
Sales / total asets less current liabilities
n/a
n/a
n/a
n/a
n/a
n/a
Sales / working capital

Sales / fixed assets
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
Sales per Irish employee (000's)
n/a
n/a
n/a
n/a
n/a
n/a
Total R&D spend (000's)

R&D as % of sales
0
n/a
0
n/a
0
n/a
0
n/a
0
n/a
0
n/a
R&D as a % of OPEX
MANAGEMENT
n/a
n/a
n/a
n/a
n/a
n/a
Asset turnover
Net Current Asset Turnover
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
Current Ratio
n/a
n/a
n/a
n/a
n/a
n/a
RESEARCH & DEVELOPMENT
WORKING CAPITAL ANALYSIS

Working Capital
Working capital (exc short term facilities) ('000s)
Short term facilities ('000s)
Working Capital Turnover (times)
0
n/a
0
n/a
0
n/a
0
n/a
0
n/a
0
n/a
Avg Dr Days
Inventory Turnover
n/a
n/a
n/a
n/a
n/a
n/a
Avg Cr Days
Total Debtors (inc pre payments) days
n/a
n/a
n/a
n/a
n/a
n/a
Interest Cover
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
n/a
n/a
n/a
n/a
n/a
n/a
0
0
0
0
0
0
0
0
0
0
0
0
Invoice Discounting as a % of Tr Debtors

Total Creditors (inc accruals) days
GEARING
Equity (Incl Shareholders Funds & Director Loans)
Total Debt
Total Bank Debt
0
0
Debt/Equity
1+( LT liabilities/S/H funds)
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
Interest Cover
n/a
n/a
n/a
n/a
n/a
n/a
Free Cash Flow (FCF)
EMPLOYMENT
Global Employees at year-end
Irish Employees at year-end
No. of R&D Employees @y/e

No. of Irish R&D Employees @ y/e
Base Employment = 0
0
0
0
0
0
0
0
0
0
0
0
0
Base Year-2
Base Year-1
Base Year
Current Year
Base Year+2
Base Year+3
31/12/11
31/12/12
Audited
Profit & Loss

Year End
31/12/13
31/12/14
31/12/15
31/12/16
Audited
Management
Projected
Projected
Projected
000's
000's
000's
000's
000's
000's
Own Product / Service Produced in Ireland & Exported
Own Product / Service Produced Abroad & sold Abroad
Own Product / Service Produced & Sold in Ireland
Distribution Sales of Other Co's Product
Total Sales
Direct Labour
Purchases
Other Cost of Goods Sold
Cost of Sales
Gross Profit/(Loss)
Selling, General & Admin Expenses
Indirect Labour (excluding R&D Salaries)
R&D Expenditure
Other Operating Expenses/(Gains)
Interest Payable
Interest / Dividends (Receivable)
Depreciation
Amortisation
Account Status
Grant Amortisation (This application only)
Remitted Profits to Ireland From Foreign Subsidiary
Non-Operating Expenses/(Gains)
Tax
Net Profit/(Loss)
Dividends
Balance Sheet
Balance Sheet: Company Name
Year End
FDS Template as at
31/12/11
31/12/12
31/12/13
41775
31/12/14
31/12/15
31/12/16
000's
000's
000's
000's
000's
000's
Intangible
Tangible Fixed Assets
Fixed Assets
Investments
Inventory
Trade Debtors
Total Fixed Assets
Current Assets
Bank/Cash
Current Liabilities
Bank Overdraft (Facility Limit in Projected Years)
Invoice discounting (YE Balance)
Trade Creditors
Net Current Assets
Long Term Loans
Leases
Directors / Shareholders Loans
Liabilities > 1 Year
EI Grant Liability (This application only)

Other Long Term Liabilities
Net Assets
Financed by
Preference Shares
EI Equity Assistance (This application only)
Ordinary Shares & Share Premium
Provisions/Grants/Other Reserves
Retained Earnings
Shareholders Funds
Capex
Loans Facilities Total
Capital Expenditure
Bank Overdraft
Invoice disc
Long Term Bank Loans/Leasing
Related Parties
Directors Loans
Bank Overdraft Payments
Invoice Discounting Payments
Short term Loan / Leasing Payments
Loans Repayment Total
Long Term Bank Loans/Leasing Payments
Other Long Term Liabilities Redeemed
Related Parties Payments
Base Year-1
Base Year
Base Year+1
Base Year+2
Base Year+3
Directors Loans Redeemed
Additional Ratios
Base Year-2
Year End
Account Status
GROWTH
Net increase in Sales
Net increase in Exports
Dec-11
Dec-12
Dec-13
Dec-14
Dec-15
Dec-16
30/12/99
30/12/99
30/12/99
30/12/99
30/12/99
30/12/99
PROFITABILITY
EBIT
EBIT as % of Sales
0
n/a
0
n/a
0
n/a
0
n/a
0
n/a
0
n/a
Purchases as a % of Sales
n/a
n/a
n/a
n/a
n/a
n/a
Direct labour as a % of Sales
n/a
n/a
n/a
n/a
n/a
n/a
SGA as a % of Gross Profit
n/a
n/a
n/a
n/a
n/a
n/a
Indirect Labour as a % of Sales
n/a
n/a
n/a
n/a
n/a
n/a
R&D as a % of Sales
n/a
n/a
n/a
n/a
n/a
n/a
Other
n/a
n/a
n/a
n/a
n/a
n/a
Depreciation-Amortization
ROCE
ROI
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
PRODUCTIVITY
Sales per total employee (000's)
Value Add To Ireland
Value Add To Ireland per Total employee
n/a
na
na
na
na
na
Value Add To Ireland per Irish employee
n/a
n/a
n/a
n/a
n/a
n/a
Std % Dr's
90
Anything above 90 days should be considered excessive - identify why
90
Anything above 90 days should be considered excessive - identify why
Anything less than 1 suggests an inability to meet finance repayments
75%
75% is the standard amount provided by the bank
Project [Name]
Payback Period without EI Support
0
The % of the company's profit increases attributed to this project:
Year:
0
1
2
3
4
*Cash Flow (,000s):
Cumulative Cash Flow - incl. at Yr.0 the Cost of Proj. as Neg. Fig. (,000s):
See Example of Payback Period Exercise at Line 48 below
Note: Base Yr. (Yr.0) Fig. above to include R&D, Capital Costs, Start-Up losses, etc
*
EI Support package not included
Payback Period:
#DIV/0!
#DIV/0!
Payback Period with EI Support

Year:
**Cash Flow (,000s):
Cumulative Cash Flow (,000s):
Assumed Stream of EI Financial Support (Years 1, 2 & 3 only):
0
1
-
0
2
-
0
3
(,000s)
**
EI Support package included

Payback Period:
Payback Period (where time period requires extension):
Adjusted Payback Period without EI Support
#DIV/0!
#DIV/0!
Assumed annual cashflow reduction due to curtailed proposal:
Year:
Cash Flow (,000s) - As per C/F above 'without EI support':
Cumulative Cash Flow (,000s):
(,000s)
1
-
2
-
3
-
4
-
0 = necessary reduction in project investment in order to bring payback

period measure in line with that required (say - as per Cell F21 above)
Payback Period:
#DIV/0!
The 'Goal Seek' function may be used to amend Assumed Costs (Blue Box above)
#DIV/0!
25%
5
-
Years
5
-
Years
Years
10%
5
-
ll F21 above)
Years

Financial Data Sheet R D Fund Large Projects

Transféré par

Informations du document

Copyright

Formats disponibles

Partager ce document

Partager ou intégrer le document

Options de partage

Avez-vous trouvé ce document utile ?

Ce contenu est-il inapproprié ?

Droits d'auteur :

Formats disponibles

Financial Data Sheet R D Fund Large Projects

Transféré par

Droits d'auteur :

Formats disponibles

Financial Data Sheet

White cells represent areas available for Company input.

Financial Data Sheet

Profit & Loss

Other Operating Expenses/(Gains)

Operating Profit/(Loss) - EBITDA

Selling, General & Admin Expenses

Company Input Sheet 1

Net Current Assets

Liabilities > 1 Year

Company Input Sheet 1

Projected Cash Funding Table

Cash Flow Statement For the year ended

Add back; Depreciation / Amortisation

Working Capital (Increase)/Decrease

Prepayments / Other Debtors

Accruals / Other Creditors

Operating Cash Inflow / (Outflow)

Funding Inc/ (Dec)

Long Term Loans / Leasing / convertible

Connected Parties / Inter Company Loans

Company Input Sheet 1

Insert Additional Information

Please provide a description of Other

Please provide a description of Other

Company Input Sheet 1

Insert Additional Information

Please provide a description of Other

Please provide a description of Other

Please provide a description of Other

Please provide a description of Other

Company Input Sheet 1

Company Input Sheet 1

Summary Monthly Cashflow Statement for the NEXT 12 MONTHS

Operating Cash Inflow

Sales Receipts - Invoice

Other Revenue - specify

Promoters' Equity Investment

EI Monies (This investment)

Operating Cash Payments

Directors Loans/ Related Parties

Invoice Discounting Payments

Total Cash Inflow/(Outflow)

Net Opening Cash (Excl Short Term

Net Closing Cash (Excl Short Term

Inv Disc (Proj Month End Bal)

Net Closing Cash (Incl Short Term

Total Cash Payments

Company Input Sheet 2

Sustainable Growth Analysis

Additional Fixed Assets

Additional Sales volume that can be funded from internal resources

Return on Total Assets

Maximum Sustainable Growth Rate= MSGR

Organic Enterprise Growth (Less external equity injections)

Is asset investment absolutely n

Movement in Net Profit

Is volume component of sales m

External Funding Capacity

What sources of external fundin

nced (Loan & Lease)

Expe ndi ture Analys is

R& D Exp end i ture

Summary of key profit & loss indicators